Elranatamab-Based Triplet Effective in Transplant-Ineligible Myeloma

(MedPage Today) — TORONTO — A three-drug combination involving the B-cell maturation antigen (BCMA)-CD3 bispecific antibody elranatamab (Elrexfio) was associated with high response rates and manageable toxicity in newly diagnosed, transplant…

Source link : https://www.medpagetoday.com/meetingcoverage/ims/117536

Author :

Publish date : 2025-09-18 21:03:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Elranatamab-Based Triplet Effective in Transplant-Ineligible Myeloma

Starting HRT in early menopause may reduce women’s risk of Alzheimer’s

New Blood Tests for Early Cancer Detection Get Some Love From House Members

Related Posts

California Aims to Improve School Nutrition by Phasing Out Some Ultraprocessed Foods

Diet Soda and Liver Risk; Pig-to-Human Liver Transplant; Golimumab Approval Expanded

People Injecting Each Other’s Blood; CDC/FDA Approval Plunges; Drug Vending Machines

Diagnosing and Treating Methotrexate-Induced Osteopathy

Diet Drinks Harder on the Liver Than Sugary Drinks?

Annual MS Drug Effective, Affordable, Convenient

California Aims to Improve School Nutrition by Phasing Out Some Ultraprocessed Foods

Diet Soda and Liver Risk; Pig-to-Human Liver Transplant; Golimumab Approval Expanded

People Injecting Each Other’s Blood; CDC/FDA Approval Plunges; Drug Vending Machines

Diagnosing and Treating Methotrexate-Induced Osteopathy

Diet Drinks Harder on the Liver Than Sugary Drinks?

Annual MS Drug Effective, Affordable, Convenient

Miranda Hart on the healing power of nature walks

In a Wild Vaccine Season, Docs Strain to Get Shots in Arms

Categories

Archives